Martin Hutchings
Dr Hutchings has been the Chairman of the EORTC lymphoma group since 2013 and a faculty member for the EHA Clinical Research Training in Haematology programme.
He is a member of the scientific committee for the European Haematology Association National and has been principal investigator or sub-investigator for >25 solid tumour and haematology phase I trials and >20 lymphoma and myeloma phase II and phase III trials. He is the national principal investigator for three mantle cell lymphoma trials (one ongoing and two planned) and three Hodgkin lymphoma trials.
He is the co-author of the international response criteria and guidelines for the use of imaging in lymphoma and the European society of Medical Oncology (ESMO) guidelines for Hodgkin lymphoma and ’ultra high-risk’ lymphomas.